Stockscreener 앱 받기
72.82
10.07%
6.66
시간 외 거래:
72.80
-0.02
-0.03%
Crispr Therapeutics Ag 주식(CRSP)의 최신 뉴스
CRISPR Therapeutics (NASDAQ:CRSP) Trading 8.2% HigherWhat's Next? - MarketBeat
Crispr Therapeutics stock hits 52-week high at 71.14 USD By Investing.com - Investing.com Australia
From 160 Licenses to $1B Raised: Australia's Largest University Opens Boston Hub to Accelerate Biotech Innovation - Stock Titan
BMO Reaffirms Outperform on CRISPR Therapeutics (CRSP) After Sirius Collaboration - MSN
Combining price and volume data for CRISPR Therapeutics AG2025 Top Gainers & Reliable Price Breakout Alerts - newser.com
CRISPR Therapeutics AG stock outlook for YEARJuly 2025 Levels & Weekly High Conviction Ideas - newser.com
Crispr Therapeutics to present preclinical data on AATD at ESGCT 2025 - TipRanks
Signal strength of CRISPR Therapeutics AG stock in tech scanners2025 Volatility Report & Real-Time Buy Zone Alerts - newser.com
CRISPR Therapeutics to Present Preclinical Data on Alpha-1 Antitrypsin Deficiency (AATD) Utilizing Novel SyNTase Gene Editing Technology at the European Society of Gene and Cell Therapy (ESGCT) 2025 Annual Congress - The Manila Times
CRISPR Therapeutics to Present Novel SyNTase Gene Editing Technology at ESGCT 2025 Annual Congress - Quiver Quantitative
Leading vs lagging indicators on CRISPR Therapeutics AG performance2025 EndofYear Setup & Growth Focused Stock Reports - newser.com
CRISPR Therapeutics to Present Preclinical Data on Alpha-1 - GlobeNewswire
What valuation ratios show for CRISPR Therapeutics AG (1CG) stockEarnings Miss & High Return Trade Opportunity Guides - newser.com
CRISPR's SyNTase Gene Editor Shows 95% Efficacy in AATD Models | CRSP Stock News - Stock Titan
Got $200? 2 Healthcare Stocks to Buy and Hold Forever - The Motley Fool
H.C. Wainwright Reiterates Buy Rating on CRISPR Therapeutics AG (CRSP) Stock - Yahoo Finance
U.S. Gene Editing Market Projections 2025-2032: Key Trends, - openPR.com
CRISPR Therapeutics AG (CRSP): the Most Oversold Pharma Stock to Buy According to Analysts - MSN
H.C. Wainwright Reaffirms Buy Rating on CRISPR Therapeutics After CTX310 Update - msn.com
Could This Beaten-Down Stock Help You Become a Millionaire? - AOL.com
Relative strength of CRISPR Therapeutics AG in sector analysisTrade Risk Summary & Fast Moving Stock Watchlists - newser.com
What analysts say about CRISPR Therapeutics AG stockVWAP Trading Strategies & Exceptional Return Opportunities - earlytimes.in
Does CRISPR Therapeutics AG qualify in momentum factor screeningPortfolio Profit Report & Stock Market Timing Techniques - newser.com
Order flow analysis tools used on CRISPR Therapeutics AG2025 Retail Activity & Fast Gain Swing Trade Alerts - newser.com
Published on: 2025-09-29 09:36:12 - newser.com
Published on: 2025-09-29 07:23:14 - newser.com
Measuring CRISPR Therapeutics AG’s beta against major indices2025 Major Catalysts & High Yield Equity Trading Tips - newser.com
Will a bounce in CRISPR Therapeutics AG offer an exit2025 Market Overview & Risk Managed Investment Entry Signals - newser.com
What candlestick patterns are forming on CRISPR Therapeutics AGJuly 2025 Catalysts & Detailed Earnings Play Strategies - newser.com
Published on: 2025-09-29 03:07:00 - newser.com
CRISPR Therapeutics AG (NASDAQ:CRSP) Receives Consensus Recommendation of "Moderate Buy" from Brokerages - MarketBeat
Published on: 2025-09-29 01:02:34 - newser.com
What drives CRISPR Therapeutics AG stock priceDividend Reinvestment Plans & Big Data Market Reports - earlytimes.in
Is CRISPR Therapeutics AG a good long term investmentSupport and Resistance Levels & Access Free Risk Analysis Before You Invest - earlytimes.in
Published on: 2025-09-27 21:01:29 - newser.com
Is the First Phase 2 Dosing of SRSD107 Shifting CRISPR Therapeutics’ (CRSP) Investment Landscape? - Sahm
Voya Investment Management LLC Boosts Stock Position in CRISPR Therapeutics AG $CRSP - MarketBeat
CRISPR Therapeutics AG (CRSP) Laps the Stock Market: Here's Why - sharewise.com
CRISPR Therapeutics AG Stock Analysis and ForecastOptions Trading Strategies & Low Risk Investment Trading - Early Times
Wealth Enhancement Advisory Services LLC Decreases Stock Holdings in CRISPR Therapeutics AG $CRSP - MarketBeat
Exchange Traded Concepts LLC Acquires New Shares in CRISPR Therapeutics AG $CRSP - MarketBeat
CRISPR Therapeutics AG (CRSP) Falls More Steeply Than Broader Market: What Investors Need to Know - sharewise.com
Bouvel Investment Partners LLC Acquires 9,458 Shares of CRISPR Therapeutics AG $CRSP - MarketBeat
BMO Capital reiterates Outperform on CRISPR Therapeutics stock, sees potential in thrombosis market - Investing.com Nigeria
Is Trending Stock CRISPR Therapeutics AG (CRSP) a Buy Now? - sharewise.com
CRSP & Sirius Begin Dosing in Thromboembolic Disorder Study in EU - Yahoo Finance
0.47%
0.48%
자본화:
|
볼륨(24시간):